Dinah Misner

Dinah Misner has 22 years of work experience in the pharmaceutical industry. Dinah currently holds the position of Vice President at Aligos Therapeutics, where they have been working since February 2022. Previously, Dinah served as Senior Director at the same company from February 2020 to February 2022, and as Director from September 2018 to February 2020. Prior to joining Aligos Therapeutics, they worked as a Scientific Director of Toxicology at Alios BioPharma from October 2016 to September 2018. Dinah also held the positions of Sr. Scientist - Toxicologist/Group Leader, Investigative Toxicology at Genentech from February 2012 to September 2016, and Principal Scientist at Celgene from May 2010 to February 2012. Dinah began their career at Roche Palo Alto in 2000, where they held various roles including Toxicology Project Leader, Group Leader, and Research Scientist. Throughout their career, Dinah has gained extensive experience in toxicology, safety assessment, and project leadership.

Dinah Misner has a strong educational background in the field of Biomedical Sciences and Biophysics. Dinah obtained a Bachelor of Science degree in Biochemistry from Worcester Polytechnic Institute, graduating in 1995. Following their undergraduate studies, Dinah pursued a Ph.D. in Biomedical Sciences at UC San Diego, which they completed in 1999. During their Ph.D. program, they focused on Biophysics and conducted research at The Salk Institute as a Post-doctoral fellow from 1999 to 2000. This experience allowed their to further enhance their expertise in Biophysics. In addition to their academic achievements, Dinah also holds the certification of DABT (Diplomate of the American Board of Toxicology, Inc.), which they obtained in January 2020. This certification highlights their proficiency in toxicology.